Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,579.60
13.05 (0.51%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 41.65 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.51%
0.48%
1W
-1.05%
1.32%
1M
7.46%
0.86%
YTD
4.4%
-7.35%
1Y
-4.88%
-1.97%
3Y
83.96%
20.14%
5Y
56.85%
45.46%
10Y
63.94%
181.19%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.22%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.41%
2.34%
8.75%
6 Months
3.77%
2.27%
6.04%
1 Year
-4.88%
2.20%
-2.68%
2 Years
-7.49%
2.35%
-5.14%
3 Years
83.96%
7.11%
91.07%
4 Years
83.23%
9.11%
92.34%
5 Years
56.85%
12.62%
69.47%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
5.25%
3
Quartile
quartile-3
Mar-Jun
7.34%
4
Quartile
quartile-4
Dec-Mar
-7.59%
4
Quartile
quartile-4
YTD
-3.71%
2
Quartile
quartile-2
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
5.25%
4
Quartile
quartile-4
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
-3.71%
1
Quartile
quartile-1
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
5.25%
3
Quartile
quartile-3
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
-3.71%
2
Quartile
quartile-2
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available